2011
DOI: 10.1128/jcm.00183-11
|View full text |Cite|
|
Sign up to set email alerts
|

New Delhi Metallo-β-Lactamase (NDM-1)-Producing Klebsiella pneumoniae: Case Report and Laboratory Detection Strategies

Abstract: The spread of antimicrobial resistance among Enterobacteriaceae is a significant clinical threat. We report the first case of an Enterobacteriaceae strain harboring the NDM-1 metallo-␤-lactamase in a pediatric patient in the United States. We describe strategies for the detection of this novel resistance mechanism encountered in an isolate of Klebsiella pneumoniae. CASE REPORTA 13-month-old boy in severe respiratory distress was brought to the emergency department (ED) by his parents following a 3-day history … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
32
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 68 publications
(35 citation statements)
references
References 6 publications
1
32
1
Order By: Relevance
“…bla NDM-1 isolates typically coexpress resistance to aminoglycosides (unlike the isolate seen here), quinolones, and trimethoprim-sulfamethoxazole (47), and resistance to last-line agents such as colistin is well described (49). bla NDM-1 still remains rare in this region, with only 5 cases reported previously in California (13,50,51) and just over 40 isolates in total reported within the whole of the United States (13,52,53). Given the rapid spread of the bla NDM-1 carbapenemase since its discovery in Europe only 5 years ago (5,54,55), timely detection and aggressive infection control approaches to both colonized or infected cases in this region are crucial to prevent its establishment as an endemic carbapenemase in California hospitals or long-term-care facilities.…”
Section: Discussionmentioning
confidence: 62%
“…bla NDM-1 isolates typically coexpress resistance to aminoglycosides (unlike the isolate seen here), quinolones, and trimethoprim-sulfamethoxazole (47), and resistance to last-line agents such as colistin is well described (49). bla NDM-1 still remains rare in this region, with only 5 cases reported previously in California (13,50,51) and just over 40 isolates in total reported within the whole of the United States (13,52,53). Given the rapid spread of the bla NDM-1 carbapenemase since its discovery in Europe only 5 years ago (5,54,55), timely detection and aggressive infection control approaches to both colonized or infected cases in this region are crucial to prevent its establishment as an endemic carbapenemase in California hospitals or long-term-care facilities.…”
Section: Discussionmentioning
confidence: 62%
“…Given the rapid international spread of NDM-producing bacteria, this is an important limitation. In addition, the MHT also suffers from poor specificity because bacteria producing AmpC enzymes combined with porin mutations can give a false-positive result (20,21,22). These limitations have resulted in a decrease in the use of MHT outside the United States where KPC is less common than other carbapenemases, but MHT remains an important part of many testing algorithms because it is simple to perform and uses reagents readily available in most microbiology laboratories.…”
Section: Phenotypic Cp-cre Detection Methodsmentioning
confidence: 99%
“…Therefore, an ideal monitoring assay should not only identify the presence of bla NDM-1 but also reveal functional bla NDM-1 variants. In view of these requirements, the current widely used PCR sequencing method is not sufficient, because phenotypic testing (expression of recombinant protein) is needed to confirm whether a new variant identified by sequencing has an alteration in the function of its coded protein (14,31).…”
Section: Discussionmentioning
confidence: 99%
“…Phenotypic techniques for detecting carbapenemase activity, such as the modified Hodge Test (MHT) recommended by the Clinical and Laboratory Standards Institute (CLSI) (14,15) and the newly developed Carba NP (16), can be used to detect carbapenemase producers, including those producing NDM-1. However, because all of the phenotypic assays detect NDM-1 together with other carbapenemases, specific molecular methods to detect the bla NDM-1 gene have been widely used to indicate the presence of NDM-1-producing bacteria (17)(18)(19)(20)(21).…”
mentioning
confidence: 99%